ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Record profit, sales seen for Nippon Shinyaku on new drugs

Recently launched products pump up Japanese pharma's vital stats

TOKYO -- Nippon Shinyaku probably earned record operating profit and sales in the year ended March, boosted by revenues from new drugs.

The Kyoto-based pharmaceutical company appears to have generated around 15.5 billion yen ($142 million) in group operating profit in fiscal 2016. That is a jump of around 80% from a year earlier. The company's standing projection calls for 13.5 billion yen.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more